We are live on ! Find out more
TD Asset Management

TD Asset Management Portfolio holdings

AUM $123B
1-Year Est. Return 34.51%
This Fund
S&P 500
This Quarter Est. Return
+8.01%
1 Year Est. Return
+34.51%
3 Year Est. Return
+98.94%
5 Year Est. Return
+122.3%
10 Year Est. Return
+375.56%
AUM
$81B
AUM Growth
+$1.17B
Cap. Flow
-$2.37B
Cap. Flow %
-2.92%
Top 10 Hldgs %
26.64%
Holding
1,562
New
88
Increased
546
Reduced
606
Closed
117

Sector Composition

Rank Sector Weight
1 Financials 20.44%
2 Technology 17.09%
3 Healthcare 11.75%
4 Industrials 8.45%
5 Energy 7.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HLVX
1351
DELISTED
HilleVax
HLVX
$310K ﹤0.01%
18,528
WHWK
1352
Whitehawk Therapeutics
WHWK
$190M
$309K ﹤0.01%
24,083
TWI icon
1353
Titan International
TWI
$466M
$306K ﹤0.01%
+20,000
New +$285K
RGNX icon
1354
Regenxbio
RGNX
$620M
$305K ﹤0.01%
13,441
ALEC icon
1355
Alector
ALEC
$168M
$304K ﹤0.01%
32,969
ZIM icon
1356
ZIM Integrated Shipping Services
ZIM
$3.04B
$301K ﹤0.01%
17,538
-400
-2% -$8.9K
ROCC
1357
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
$295K ﹤0.01%
7,300
-18,600
-72% -$737K
BOOT icon
1358
Boot Barn
BOOT
$4.51B
$294K ﹤0.01%
+4,700
New +$282K
LIAN
1359
DELISTED
LianBio American Depositary Shares
LIAN
$293K ﹤0.01%
178,519
LXP icon
1360
LXP Industrial Trust
LXP
$3.57B
$292K ﹤0.01%
5,820
ADCT icon
1361
ADC Therapeutics
ADCT
$134M
$287K ﹤0.01%
74,690
CCCC icon
1362
C4 Therapeutics
CCCC
$385M
$286K ﹤0.01%
48,453
FXI icon
1363
iShares China Large-Cap ETF
FXI
$4.37B
$280K ﹤0.01%
9,881
-230
-2% -$5.95K
SKE
1364
Skeena Resources
SKE
$3.3B
$274K ﹤0.01%
51,556
+5,400
+12% +$27.4K
ODP
1365
DELISTED
ODP
ODP
$273K ﹤0.01%
+6,000
New +$256K
IDYA icon
1366
IDEAYA Biosciences
IDYA
$3.42B
$264K ﹤0.01%
14,502
SHOE
1367
Shoe Station Group
SHOE
$413M
$258K ﹤0.01%
10,800
CNXN icon
1368
PC Connection
CNXN
$2.11B
$258K ﹤0.01%
5,500
VIAV icon
1369
Viavi Solutions
VIAV
$9.12B
$257K ﹤0.01%
+24,500
New +$295K
EQRX
1370
DELISTED
EQRx, Inc. Common Stock
EQRX
$255K ﹤0.01%
103,835
UNIT
1371
Uniti Group
UNIT
$2.36B
$255K ﹤0.01%
+46,100
New +$317K
CNTA
1372
DELISTED
Centessa Pharmaceuticals
CNTA
$254K ﹤0.01%
82,055
CVAC
1373
DELISTED
CureVac
CVAC
$244K ﹤0.01%
+40,500
New +$299K
STOK icon
1374
Stoke Therapeutics
STOK
$1.8B
$242K ﹤0.01%
26,186
DBI icon
1375
Designer Brands
DBI
$307M
$233K ﹤0.01%
+23,800
New +$321K

Similar funds

TD Asset Management's Q4 2022 Portfolio in Review

As of Q4 2022, TD Asset Management held 1,562 positions worth $81B, up 1.5% from $79.9B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

TD Asset Management's Q4 2022 filing shows 88 new, 546 increased, 606 reduced and 117 closed positions. Its largest new stake was Brookfield Asset Management: 7,008,054 shares worth $201M. The largest sale was Alphabet (Google) Class C, an estimated $396M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.

  • TD Asset Management's largest Q4 2022 buy was Brookfield Asset Management: 7,008,054 shares worth $201M.
  • TD Asset Management added most to iShares MSCI Japan ETF in Q4 2022, an estimated $258M increase.
  • TD Asset Management's biggest Q4 2022 reduction was Alphabet (Google) Class C, cutting an estimated $396M.
  • TD Asset Management fully exited Corcept Therapeutics in Q4 2022, selling an estimated $25.4M.
  • TD Asset Management's ten largest holdings make up 27% of its $81B portfolio in Q4 2022.
  • TD Asset Management opened 88 new positions and closed 117 in Q4 2022.
  • TD Asset Management's portfolio value rose 1.5% quarter-over-quarter to $81B.

Based on TD Asset Management's 13F filing for Q4 2022, filed 7 Feb 2023.